MeSH D020031 - epstein-barr virus infections
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Bausch Health Companies | Hydrocortisone, Acyclovir | Xerese |  | 2009-07-31 |  |  |
1
2
3
4
5
>
Clinical Trials
Historical Success Rate
Phase 1
57%4/7
Phase 2
38%6/16
Phase 3
25%2/8
Approved: 2Overall Success rate: 5%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
1
2
3
4
>
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use